Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden ; volume:74 ; number:7 ; day:9 ; month:4 ; year:2018 ; pages:971-978 ; date:7.2018
European journal of clinical pharmacology ; 74, Heft 7 (9.4.2018), 971-978, 7.2018
- Urheber
-
Frisk, P.
- Beteiligte Personen und Organisationen
-
Aggefors, K.
Cars, T.
Feltelius, N.
Loov, S. A.
Wettermark, B.
Weiland, O.
SpringerLink (Online service)
- DOI
-
10.1007/s00228-018-2456-y
- URN
-
urn:nbn:de:101:1-2018082123265125857084
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Frisk, P.
- Aggefors, K.
- Cars, T.
- Feltelius, N.
- Loov, S. A.
- Wettermark, B.
- Weiland, O.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection